{"id":"W1999075488","doi":"10.1007/s10227-006-0104-0","title":"Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis","year":2005,"lang":"en","type":"review","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Guenther Dermatology Research Centre; University of Calgary; University of Manitoba; Sunnybrook Health Science Centre; Université Laval; Lynde Centre for Dermatology; Queen Elizabeth II Health Sciences Centre; University of Toronto; Dalhousie University; University Health Network; University of British Columbia; Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Adverse effect; Intensive care medicine; Drug; Disease; Clinical trial; Dermatology; Plaque psoriasis; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007923341,0.0008011945,0.001596111,0.002501761,0.000288995,0.0008563746,0.001017007,0.001356793,0.003289566],"category_scores_gemma":[0.0007672459,0.000276828,0.0004972829,0.001354207,0.0004750041,0.00111261,0.0003646909,0.001964833,0.002697117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006615231,"about_ca_system_score_gemma":0.0006885323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001108054,"about_ca_topic_score_gemma":0.00234574,"domain_scores_codex":[0.9997738,0.00005281284,0.0000390531,0.00002749561,0.00009057044,0.00001617441],"domain_scores_gemma":[0.9997639,0.0001029244,0.00004140921,0.000007789832,0.00005792566,0.00002614624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008252537,0.0001452781,0.0002579406,0.005140249,0.00007424475,0.0004598091,0.00005500495,0.000403998,0.001412045,0.00323525,0.02833972,0.9603938],"study_design_scores_gemma":[0.00008328707,0.0001407128,0.002044903,0.00308895,0.0001066959,0.003412356,0.00008278075,0.0001980181,0.0005606637,0.003426233,0.9868333,0.00002204933],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002439538,0.9960713,0.0004638513,0.0008830553,0.0003006558,0.00001279906,0.00001600343,0.0000220172,0.001986325],"genre_scores_gemma":[0.001680963,0.9948797,0.001332426,0.0005904757,0.0003658305,0.00002335295,0.000037595,0.000003507427,0.001086171],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003289566,"threshold_uncertainty_score":0.01100475,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06254265068135623,"score_gpt":0.3123617089270362,"score_spread":0.24981905824568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}